Trial
NCT06673368
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Neurocentria, Inc.
Collaborators
—
Condition
ADHD
Intervention
NRCT-101SR, NRCT-202XR
Why stopped
Slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-15